Embedded Files
Session 4 (10:00am-11:55 am CST, Saturday Oct 16)
Session 4 (10:00am-11:55 am CST, Saturday Oct 16)
Scriptors : RNA localization, efflux and metabolism in heart
Scriptors : RNA localization, efflux and metabolism in heart
Moderators
Moderators
Srikanth Garikipati, PhD
Srikanth Garikipati, PhD
The Ohio State University
Columbus, USA
10:00-10:20 am CST
Circular RNAs as novel therapeutic targets for cardiovascular disease
Circular RNAs as novel therapeutic targets for cardiovascular disease
Anna University
Chennai, India
10:20-10:40 am CST
Emerging role of LncRNAs in Diabetic cardiomyopathy
Emerging role of LncRNAs in Diabetic cardiomyopathy
Technion-Israel Institute of Technology
Israel
10:40-11:00 am CST
Spatiotemporal maintenance of sarcomeric RNA and proteins
Spatiotemporal maintenance of sarcomeric RNA and proteins
Indiana University
Indianapolis, USA
11:00-11:20 am CST
β-arrestin-mediated β-adrenergic receptor signaling and microRNA biogenesis in heart failure
β-arrestin-mediated β-adrenergic receptor signaling and microRNA biogenesis in heart failure
Kansas City University
Kansas City, USA
11:20-11:40 am CST
Noncoding scaRNAs influence alternative splicing of mRNA and heart development
Noncoding scaRNAs influence alternative splicing of mRNA and heart development
Trainee presentation
Trainee presentation
Vinoth Sigamani, M.Tech
Vinoth Sigamani, M.Tech
The University of Tennessee Health Science Center
Memphis, USA
11:40-11:55 am CST
Beneficial Effect of scaRNA20 in iPSC-derived Cardiomyocytes under Hypoxic Environment
Beneficial Effect of scaRNA20 in iPSC-derived Cardiomyocytes under Hypoxic Environment
Break
Break
Session 5 (12:00pm-1:20 pm CST, Saturday Oct 16)
Session 5 (12:00pm-1:20 pm CST, Saturday Oct 16)
Residents : Fibroblasts and endothelial cells, role and contribution in cardiac pathophysiology
Residents : Fibroblasts and endothelial cells, role and contribution in cardiac pathophysiology
Moderators
Moderators
University of Strathclyde
Glasgow, UK
12:00-12:20 pm CST
Cardiotoxicity and the cardiac fibroblast
Cardiotoxicity and the cardiac fibroblast
The University of Illinois at Chicago
Chicago, USA
12:20-12:40 pm CST
The Role of KLF4 in Idiopathic Pulmonary Fibrosis
The Role of KLF4 in Idiopathic Pulmonary Fibrosis
The University of Chicago
Chicago, USA
12:40-1:00 pm CST
HIF1/ARNT is a novel regulator of cardiac homeostasis and disease
HIF1/ARNT is a novel regulator of cardiac homeostasis and disease
Universite De Sherbrooke,
Quebec, Canada
1:00-1:20 pm CST
Targeting the apelinergic system in cardiovascular diseases
Targeting the apelinergic system in cardiovascular diseases
Break
Break
Session 6 (1:30pm-3:20 pm CST, Saturday Oct 16)
Session 6 (1:30pm-3:20 pm CST, Saturday Oct 16)
Imitators : Stem cells in cardiovascular regeneration and therapeutics
Imitators : Stem cells in cardiovascular regeneration and therapeutics
Moderators
Moderators
Augusta University
Augusta, USA
1:30-1:50 pm CST
Notch responsive H19X regulates neovascularization via HIF-1α Signaling
Notch responsive H19X regulates neovascularization via HIF-1α Signaling
Stanford University
Stanford, USA
1:50-2:10 pm CST
Identifying Therapeutic Drugs using iPSCs for LMNA associated cardiomyopathy
Identifying Therapeutic Drugs using iPSCs for LMNA associated cardiomyopathy
Narasimman Gurusamy, PhD
Narasimman Gurusamy, PhD
The University of Tennessee Health Science Center
Memphis, USA
2:10-2:30 pm CST
Non-invasively derived human induced-mesenchymal stem cells from urinary epithelial cells for regenerative therapy
Non-invasively derived human induced-mesenchymal stem cells from urinary epithelial cells for regenerative therapy
Trainee presentation
Trainee presentation
Sarojini Singh, PhD
Sarojini Singh, PhD
The University of Alabama at Birmingham,
Alabama, USA
2:30-2:50 pm CST
Effects of Depression on Cardiac Pathophysiology
Effects of Depression on Cardiac Pathophysiology
Trainee presentation
Trainee presentation
Abhay Srivastava
Abhay Srivastava
St-Boniface Hospital Research
Winnipeg, Canada
2:50-3:05 pm CST
Induced pluripotent stem cell-based clinical trial selection platform for patients with in-born metabolic disorders
Induced pluripotent stem cell-based clinical trial selection platform for patients with in-born metabolic disorders
Weiang Yan
Weiang Yan
Weiang Yan
Weiang Yan
St-Boniface Hospital Research
Winnipeg, Canada
3:05-3:20 pm CST
Next-Generation immunomodulatory Materials for Cardiovascular Medicine
Next-Generation immunomodulatory Materials for Cardiovascular Medicine
Closing Remarks and Thanks
Closing Remarks and Thanks
Dr. Danish Sayed & Dr. Rajasingh Johnson
Dr. Danish Sayed & Dr. Rajasingh Johnson
Page updated
Google Sites
Report abuse